New drug combo tested for blood cancer treatment
NCT ID NCT02412228
Summary
This study tested a combination of three medications (ixazomib, cyclophosphamide, and dexamethasone) as the first treatment for adults with multiple myeloma, a type of blood cancer. The goal was to see if this combination could control the disease effectively while causing fewer nerve-related side effects than some existing treatments. Researchers measured how well the treatment worked and what side effects patients experienced.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Memorial Hospital of Rhode Island
Pawtucket, Rhode Island, 02860, United States
-
Rhode Island Hospital
Providence, Rhode Island, 02903, United States
-
The Miriam Hospital
Providence, Rhode Island, 02906, United States
Conditions
Explore the condition pages connected to this study.